Oncology Hematology Care, Inc. - Blue Ash

Cincinnati, OH

Sorting 2 by

Accepting patients

QUINTESSENTIAL

A Phase 2, Open-Label, Multicenter Study of BMS-986393, a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)
Learn more
  • CAR T Cell
  • GPRC5D
  • Phase 2

Accepting patients

Teclistamab or Talquetamab

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Learn more
  • Bispecific Antibody
  • BCMA
  • Phase 2
  • Has results